Abstract
The aim of this review is to present the increased frequency of influenza-associated invasive pulmonary aspergillosis (IPA) cases reported from several countries. Classic risk factors or additional immunosuppression may not be observed in affected patients. Therefore, influenza-associated IPA might be diagnosed with a delay and consequently result in worse patient outcomes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
